Global Restless Legs Syndrome Market Size, Status and Forecast 2020-2026

May 2020 | 95 pages | ID: G4EF4BE345C8EN
QYResearch

Abstracts

This report focuses on the global Restless Legs Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Restless Legs Syndrome development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• GlaxoSmithKline plc.
• Ligand Pharmaceuticals Incorporated
• axxonis Pharma AG
• Kyowa Hakko Kirin
• Jazz Pharmaceuticals
• Omeros Corporation
• Manhattan Pharmaceuticals
• Boehringer Ingelheim GmbH
• UCB SA

Market segment by Type, the product can be split into

• Pharmacological Therapy
• Non-Pharmacological Therapy

Market segment by Application, split into

• Below 35 YearsOld
• 35-50 Years Old
• Above50 YearsOld

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Restless Legs Syndrome status, future forecast, growth opportunity, key market and key players.
• To present the Restless Legs Syndrome development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Restless Legs Syndrome are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Restless Legs Syndrome Revenue
1.4 Market Analysis by Type
  1.4.1 Global Restless Legs Syndrome Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Pharmacological Therapy
  1.4.3 Non-Pharmacological Therapy
1.5 Market by Application
  1.5.1 Global Restless Legs Syndrome Market Share by Application: 2020 VS 2026
  1.5.2 Below 35 YearsOld
  1.5.3 35-50 Years Old
  1.5.4 Above50 YearsOld
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Restless Legs Syndrome Market Perspective (2015-2026)
2.2 Restless Legs Syndrome Growth Trends by Regions
  2.2.1 Restless Legs Syndrome Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Restless Legs Syndrome Historic Market Share by Regions (2015-2020)
  2.2.3 Restless Legs Syndrome Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Restless Legs Syndrome Market Growth Strategy
  2.3.6 Primary Interviews with Key Restless Legs Syndrome Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Restless Legs Syndrome Players by Market Size
  3.1.1 Global Top Restless Legs Syndrome Players by Revenue (2015-2020)
  3.1.2 Global Restless Legs Syndrome Revenue Market Share by Players (2015-2020)
  3.1.3 Global Restless Legs Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Restless Legs Syndrome Market Concentration Ratio
  3.2.1 Global Restless Legs Syndrome Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Restless Legs Syndrome Revenue in 2019
3.3 Restless Legs Syndrome Key Players Head office and Area Served
3.4 Key Players Restless Legs Syndrome Product Solution and Service
3.5 Date of Enter into Restless Legs Syndrome Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Restless Legs Syndrome Historic Market Size by Type (2015-2020)
4.2 Global Restless Legs Syndrome Forecasted Market Size by Type (2021-2026)

5 RESTLESS LEGS SYNDROME BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Restless Legs Syndrome Market Size by Application (2015-2020)
5.2 Global Restless Legs Syndrome Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Restless Legs Syndrome Market Size (2015-2020)
6.2 Restless Legs Syndrome Key Players in North America (2019-2020)
6.3 North America Restless Legs Syndrome Market Size by Type (2015-2020)
6.4 North America Restless Legs Syndrome Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Restless Legs Syndrome Market Size (2015-2020)
7.2 Restless Legs Syndrome Key Players in Europe (2019-2020)
7.3 Europe Restless Legs Syndrome Market Size by Type (2015-2020)
7.4 Europe Restless Legs Syndrome Market Size by Application (2015-2020)

8 CHINA

8.1 China Restless Legs Syndrome Market Size (2015-2020)
8.2 Restless Legs Syndrome Key Players in China (2019-2020)
8.3 China Restless Legs Syndrome Market Size by Type (2015-2020)
8.4 China Restless Legs Syndrome Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Restless Legs Syndrome Market Size (2015-2020)
9.2 Restless Legs Syndrome Key Players in Japan (2019-2020)
9.3 Japan Restless Legs Syndrome Market Size by Type (2015-2020)
9.4 Japan Restless Legs Syndrome Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Restless Legs Syndrome Market Size (2015-2020)
10.2 Restless Legs Syndrome Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Restless Legs Syndrome Market Size by Type (2015-2020)
10.4 Southeast Asia Restless Legs Syndrome Market Size by Application (2015-2020)

11 INDIA

11.1 India Restless Legs Syndrome Market Size (2015-2020)
11.2 Restless Legs Syndrome Key Players in India (2019-2020)
11.3 India Restless Legs Syndrome Market Size by Type (2015-2020)
11.4 India Restless Legs Syndrome Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Restless Legs Syndrome Market Size (2015-2020)
12.2 Restless Legs Syndrome Key Players in Central & South America (2019-2020)
12.3 Central & South America Restless Legs Syndrome Market Size by Type (2015-2020)
12.4 Central & South America Restless Legs Syndrome Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 GlaxoSmithKline plc.
  13.1.1 GlaxoSmithKline plc. Company Details
  13.1.2 GlaxoSmithKline plc. Business Overview and Its Total Revenue
  13.1.3 GlaxoSmithKline plc. Restless Legs Syndrome Introduction
  13.1.4 GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2015-2020))
  13.1.5 GlaxoSmithKline plc. Recent Development
13.2 Ligand Pharmaceuticals Incorporated
  13.2.1 Ligand Pharmaceuticals Incorporated Company Details
  13.2.2 Ligand Pharmaceuticals Incorporated Business Overview and Its Total Revenue
  13.2.3 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Introduction
  13.2.4 Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2015-2020)
  13.2.5 Ligand Pharmaceuticals Incorporated Recent Development
13.3 axxonis Pharma AG
  13.3.1 axxonis Pharma AG Company Details
  13.3.2 axxonis Pharma AG Business Overview and Its Total Revenue
  13.3.3 axxonis Pharma AG Restless Legs Syndrome Introduction
  13.3.4 axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2015-2020)
  13.3.5 axxonis Pharma AG Recent Development
13.4 Kyowa Hakko Kirin
  13.4.1 Kyowa Hakko Kirin Company Details
  13.4.2 Kyowa Hakko Kirin Business Overview and Its Total Revenue
  13.4.3 Kyowa Hakko Kirin Restless Legs Syndrome Introduction
  13.4.4 Kyowa Hakko Kirin Revenue in Restless Legs Syndrome Business (2015-2020)
  13.4.5 Kyowa Hakko Kirin Recent Development
13.5 Jazz Pharmaceuticals
  13.5.1 Jazz Pharmaceuticals Company Details
  13.5.2 Jazz Pharmaceuticals Business Overview and Its Total Revenue
  13.5.3 Jazz Pharmaceuticals Restless Legs Syndrome Introduction
  13.5.4 Jazz Pharmaceuticals Revenue in Restless Legs Syndrome Business (2015-2020)
  13.5.5 Jazz Pharmaceuticals Recent Development
13.6 Omeros Corporation
  13.6.1 Omeros Corporation Company Details
  13.6.2 Omeros Corporation Business Overview and Its Total Revenue
  13.6.3 Omeros Corporation Restless Legs Syndrome Introduction
  13.6.4 Omeros Corporation Revenue in Restless Legs Syndrome Business (2015-2020)
  13.6.5 Omeros Corporation Recent Development
13.7 Manhattan Pharmaceuticals
  13.7.1 Manhattan Pharmaceuticals Company Details
  13.7.2 Manhattan Pharmaceuticals Business Overview and Its Total Revenue
  13.7.3 Manhattan Pharmaceuticals Restless Legs Syndrome Introduction
  13.7.4 Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2015-2020)
  13.7.5 Manhattan Pharmaceuticals Recent Development
13.8 Boehringer Ingelheim GmbH
  13.8.1 Boehringer Ingelheim GmbH Company Details
  13.8.2 Boehringer Ingelheim GmbH Business Overview and Its Total Revenue
  13.8.3 Boehringer Ingelheim GmbH Restless Legs Syndrome Introduction
  13.8.4 Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2015-2020)
  13.8.5 Boehringer Ingelheim GmbH Recent Development
13.9 UCB SA
  13.9.1 UCB SA Company Details
  13.9.2 UCB SA Business Overview and Its Total Revenue
  13.9.3 UCB SA Restless Legs Syndrome Introduction
  13.9.4 UCB SA Revenue in Restless Legs Syndrome Business (2015-2020)
  13.9.5 UCB SA Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Restless Legs Syndrome Key Market Segments
Table 2. Key Players Covered: Ranking by Restless Legs Syndrome Revenue
Table 3. Ranking of Global Top Restless Legs Syndrome Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Restless Legs Syndrome Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Pharmacological Therapy
Table 6. Key Players of Non-Pharmacological Therapy
Table 7. Global Restless Legs Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Restless Legs Syndrome Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Restless Legs Syndrome Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Restless Legs Syndrome Market Share by Regions (2015-2020)
Table 11. Global Restless Legs Syndrome Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Restless Legs Syndrome Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Restless Legs Syndrome Market Growth Strategy
Table 17. Main Points Interviewed from Key Restless Legs Syndrome Players
Table 18. Global Restless Legs Syndrome Revenue by Players (2015-2020) (Million US$)
Table 19. Global Restless Legs Syndrome Market Share by Players (2015-2020)
Table 20. Global Top Restless Legs Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Restless Legs Syndrome as of 2019)
Table 21. Global Restless Legs Syndrome by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Restless Legs Syndrome Product Solution and Service
Table 24. Date of Enter into Restless Legs Syndrome Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Restless Legs Syndrome Market Size by Type (2015-2020) (Million US$)
Table 27. Global Restless Legs Syndrome Market Size Share by Type (2015-2020)
Table 28. Global Restless Legs Syndrome Revenue Market Share by Type (2021-2026)
Table 29. Global Restless Legs Syndrome Market Size Share by Application (2015-2020)
Table 30. Global Restless Legs Syndrome Market Size by Application (2015-2020) (Million US$)
Table 31. Global Restless Legs Syndrome Market Size Share by Application (2021-2026)
Table 32. North America Key Players Restless Legs Syndrome Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Restless Legs Syndrome Market Share (2019-2020)
Table 34. North America Restless Legs Syndrome Market Size by Type (2015-2020) (Million US$)
Table 35. North America Restless Legs Syndrome Market Share by Type (2015-2020)
Table 36. North America Restless Legs Syndrome Market Size by Application (2015-2020) (Million US$)
Table 37. North America Restless Legs Syndrome Market Share by Application (2015-2020)
Table 38. Europe Key Players Restless Legs Syndrome Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Restless Legs Syndrome Market Share (2019-2020)
Table 40. Europe Restless Legs Syndrome Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Restless Legs Syndrome Market Share by Type (2015-2020)
Table 42. Europe Restless Legs Syndrome Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Restless Legs Syndrome Market Share by Application (2015-2020)
Table 44. China Key Players Restless Legs Syndrome Revenue (2019-2020) (Million US$)
Table 45. China Key Players Restless Legs Syndrome Market Share (2019-2020)
Table 46. China Restless Legs Syndrome Market Size by Type (2015-2020) (Million US$)
Table 47. China Restless Legs Syndrome Market Share by Type (2015-2020)
Table 48. China Restless Legs Syndrome Market Size by Application (2015-2020) (Million US$)
Table 49. China Restless Legs Syndrome Market Share by Application (2015-2020)
Table 50. Japan Key Players Restless Legs Syndrome Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Restless Legs Syndrome Market Share (2019-2020)
Table 52. Japan Restless Legs Syndrome Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Restless Legs Syndrome Market Share by Type (2015-2020)
Table 54. Japan Restless Legs Syndrome Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Restless Legs Syndrome Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Restless Legs Syndrome Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Restless Legs Syndrome Market Share (2019-2020)
Table 58. Southeast Asia Restless Legs Syndrome Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Restless Legs Syndrome Market Share by Type (2015-2020)
Table 60. Southeast Asia Restless Legs Syndrome Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Restless Legs Syndrome Market Share by Application (2015-2020)
Table 62. India Key Players Restless Legs Syndrome Revenue (2019-2020) (Million US$)
Table 63. India Key Players Restless Legs Syndrome Market Share (2019-2020)
Table 64. India Restless Legs Syndrome Market Size by Type (2015-2020) (Million US$)
Table 65. India Restless Legs Syndrome Market Share by Type (2015-2020)
Table 66. India Restless Legs Syndrome Market Size by Application (2015-2020) (Million US$)
Table 67. India Restless Legs Syndrome Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Restless Legs Syndrome Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Restless Legs Syndrome Market Share (2019-2020)
Table 70. Central & South America Restless Legs Syndrome Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Restless Legs Syndrome Market Share by Type (2015-2020)
Table 72. Central & South America Restless Legs Syndrome Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Restless Legs Syndrome Market Share by Application (2015-2020)
Table 74. GlaxoSmithKline plc. Company Details
Table 75. GlaxoSmithKline plc. Business Overview
Table 76. GlaxoSmithKline plc. Product
Table 77. GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2015-2020) (Million US$)
Table 78. GlaxoSmithKline plc. Recent Development
Table 79. Ligand Pharmaceuticals Incorporated Company Details
Table 80. Ligand Pharmaceuticals Incorporated Business Overview
Table 81. Ligand Pharmaceuticals Incorporated Product
Table 82. Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2015-2020) (Million US$)
Table 83. Ligand Pharmaceuticals Incorporated Recent Development
Table 84. axxonis Pharma AG Company Details
Table 85. axxonis Pharma AG Business Overview
Table 86. axxonis Pharma AG Product
Table 87. axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2015-2020) (Million US$)
Table 88. axxonis Pharma AG Recent Development
Table 89. Kyowa Hakko Kirin Company Details
Table 90. Kyowa Hakko Kirin Business Overview
Table 91. Kyowa Hakko Kirin Product
Table 92. Kyowa Hakko Kirin Revenue in Restless Legs Syndrome Business (2015-2020) (Million US$)
Table 93. Kyowa Hakko Kirin Recent Development
Table 94. Jazz Pharmaceuticals Company Details
Table 95. Jazz Pharmaceuticals Business Overview
Table 96. Jazz Pharmaceuticals Product
Table 97. Jazz Pharmaceuticals Revenue in Restless Legs Syndrome Business (2015-2020) (Million US$)
Table 98. Jazz Pharmaceuticals Recent Development
Table 99. Omeros Corporation Company Details
Table 100. Omeros Corporation Business Overview
Table 101. Omeros Corporation Product
Table 102. Omeros Corporation Revenue in Restless Legs Syndrome Business (2015-2020) (Million US$)
Table 103. Omeros Corporation Recent Development
Table 104. Manhattan Pharmaceuticals Company Details
Table 105. Manhattan Pharmaceuticals Business Overview
Table 106. Manhattan Pharmaceuticals Product
Table 107. Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2015-2020) (Million US$)
Table 108. Manhattan Pharmaceuticals Recent Development
Table 109. Boehringer Ingelheim GmbH Business Overview
Table 110. Boehringer Ingelheim GmbH Product
Table 111. Boehringer Ingelheim GmbH Company Details
Table 112. Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2015-2020) (Million US$)
Table 113. Boehringer Ingelheim GmbH Recent Development
Table 114. UCB SA Company Details
Table 115. UCB SA Business Overview
Table 116. UCB SA Product
Table 117. UCB SA Revenue in Restless Legs Syndrome Business (2015-2020) (Million US$)
Table 118. UCB SA Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Restless Legs Syndrome Market Share by Type: 2020 VS 2026
Figure 2. Pharmacological Therapy Features
Figure 3. Non-Pharmacological Therapy Features
Figure 4. Global Restless Legs Syndrome Market Share by Application: 2020 VS 2026
Figure 5. Below 35 YearsOld Case Studies
Figure 6. 35-50 Years Old Case Studies
Figure 7. Above50 YearsOld Case Studies
Figure 8. Restless Legs Syndrome Report Years Considered
Figure 9. Global Restless Legs Syndrome Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Restless Legs Syndrome Market Share by Regions: 2020 VS 2026
Figure 11. Global Restless Legs Syndrome Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Restless Legs Syndrome Market Share by Players in 2019
Figure 14. Global Top Restless Legs Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Restless Legs Syndrome as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Restless Legs Syndrome Revenue in 2019
Figure 16. North America Restless Legs Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Restless Legs Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Restless Legs Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Restless Legs Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Restless Legs Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Restless Legs Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Restless Legs Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. GlaxoSmithKline plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. GlaxoSmithKline plc. Revenue Growth Rate in Restless Legs Syndrome Business (2015-2020)
Figure 25. Ligand Pharmaceuticals Incorporated Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Ligand Pharmaceuticals Incorporated Revenue Growth Rate in Restless Legs Syndrome Business (2015-2020)
Figure 27. axxonis Pharma AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. axxonis Pharma AG Revenue Growth Rate in Restless Legs Syndrome Business (2015-2020)
Figure 29. Kyowa Hakko Kirin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Kyowa Hakko Kirin Revenue Growth Rate in Restless Legs Syndrome Business (2015-2020)
Figure 31. Jazz Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Jazz Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2015-2020)
Figure 33. Omeros Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Omeros Corporation Revenue Growth Rate in Restless Legs Syndrome Business (2015-2020)
Figure 35. Manhattan Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Manhattan Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2015-2020)
Figure 37. Boehringer Ingelheim GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Boehringer Ingelheim GmbH Revenue Growth Rate in Restless Legs Syndrome Business (2015-2020)
Figure 39. UCB SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. UCB SA Revenue Growth Rate in Restless Legs Syndrome Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed